In millions, except per share items | Feb-28-22 | Feb-28-21 | Feb-29-20 | Feb-28-19 | Feb-28-18 | Feb-28-17 | Feb-29-16 | Feb-28-15 |
| 10-K | 10-K | 10-K | 10-K | 10-K/A | 10-K | 10-K | 10-K |
Total revenues [+] | 22.9 | 0.0 | 0.4 | 0.5 | -0.2 | 0.4 | 0.5 | 1.1 |
Services | | | | | | 0.4 | 0.5 | 0.3 |
Advertising | | | | | | | | 0.8 |
Revenue growth | | -100.0% | -12.6% | -323.7% | -156.4% | -26.5% | -50.2% | -30.1% |
Cost of goods sold | 2.3 | 0.0 | 0.4 | 0.4 | -0.3 | 0.4 | 0.2 | 0.4 |
Gross profit | 20.5 | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | 0.3 | 0.7 |
Gross margin | 89.7% | | 20.1% | 20.7% | -45.4% | 10.3% | 60.1% | 67.4% |
Selling, general and administrative [+] | 19.3 | 1.1 | 3.9 | 3.3 | 4.2 | 5.3 | 3.8 | 6.4 |
Sales and marketing | 1.1 | 0.0 | 0.1 | | | 0.2 | 0.0 | 0.2 |
General and administrative [+] | 18.2 | 1.1 | 3.8 | 3.3 | 4.2 | 3.5 | 2.0 | 3.7 |
Wages and related expenses | 5.7 | 0.3 | 1.8 | 1.4 | 1.6 | | | |
General and administrative expenses | 12.5 | 0.8 | 2.0 | 1.9 | 2.6 | 3.5 | 2.0 | 3.7 |
Other selling, general and administrative | | | | | | 1.5 | 1.8 | 2.5 |
Research and development | 1.0 | 0.0 | 1.4 | 1.1 | 0.5 | 0.2 | 0.1 | 0.3 |
Other operating expenses | 32.5 | 0.5 | 0.7 | -4.3 | 3.3 | 1.5 | 0.1 | -5.6 |
EBITDA [+] | -26.7 | -1.1 | -5.7 | 0.3 | -7.7 | -5.2 | -3.5 | 0.9 |
EBITDA growth | 2284.6% | -80.3% | -1894.8% | -104.1% | 48.6% | 47.7% | -510.1% | -113.7% |
EBITDA margin | -116.6% | | -1284.0% | 62.6% | 3389.2% | -1287.1% | -640.6% | 77.8% |
Depreciation | 1.7 | 0.0 | 0.0 | | 0.2 | | | 0.0 |
EBITA | -28.4 | -1.1 | -5.7 | 0.3 | -7.9 | -5.2 | -3.5 | 0.8 |
EBITA margin | -124.0% | | -1284.3% | 62.6% | 3482.7% | -1287.1% | -640.6% | 76.7% |
Amortization of intangibles | 3.9 | 0.5 | 0.3 | 0.3 | | 1.8 | 0.2 | 1.3 |
EBIT [+] | -32.3 | -1.6 | -6.0 | 0.0 | -7.9 | -6.9 | -3.7 | -0.4 |
EBIT growth | 1942.4% | -73.5% | -26957.0% | -100.3% | 13.5% | 89.7% | 774.6% | -94.5% |
EBIT margin | -141.1% | | -1350.8% | 4.4% | 3482.7% | -1731.7% | -670.8% | -38.2% |
Non-recurring items [+] | -11.6 | | | 5.3 | -0.1 | | -0.1 | 5.7 |
Asset impairment | -11.6 | | | | | | | 0.1 |
Loss (gain) on sale of assets | | | | 5.3 | | | | |
Unusual expense | | | | | | | | 5.6 |
Legal settlement | | | | | -0.1 | | -0.1 | |
Interest expense | 2.5 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.4 | 1.1 |
Interest expense | 2.5 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.4 | 1.1 |
Other income (expense), net [+] | -17.2 | 0.0 | -3.3 | 9.7 | 7.9 | 0.1 | -0.6 | 4.2 |
Impairment of equity method investments | | | | | | | | -0.9 |
Gain (loss) on sale of assets | | | | | | | | -0.9 |
Gain (loss) on investments | -2.4 | | -5.3 | | | | | |
Realized gain (loss) on investments | -0.1 | | 2.0 | 0.0 | | 0.1 | | |
Gain (loss) on debt retirement | | | | | | 0.1 | -0.5 | 0.0 |
Unrealized gain/loss on derivatives | | | | 4.5 | | | | |
Change in fair value of warrants | | | | 4.5 | | | | |
Other | -0.1 | 0.0 | 2.0 | 0.0 | -0.1 | 0.1 | 0.0 | 0.2 |
Pre-tax income | -40.4 | -1.6 | -9.5 | 4.3 | 0.0 | -7.1 | -4.6 | -3.0 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.6 |
Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | | 0.0% | 0.0% | 53.6% |
Minority interest | -38.0 | -1.2 | | | | | | -1.6 |
Net income | -40.4 | -1.6 | -9.5 | 4.3 | -10.0 | -7.1 | -4.6 | -1.4 |
Net margin | -176.7% | | -2140.2% | 850.9% | 4443.7% | -1773.1% | -835.5% | -126.8% |
|
Basic EPS [+] | ($0.40) | ($0.03) | ($0.80) | $0.50 | ($1.61) | ($2.06) | ($1.56) | ($3.38) |
Growth | 1434.9% | -96.7% | -261.2% | -130.9% | -21.6% | 31.9% | -53.7% | 187.2% |
Diluted EPS [+] | ($0.40) | ($0.03) | ($0.80) | $0.50 | ($1.61) | ($2.06) | ($1.56) | ($3.38) |
Growth | 1434.9% | -96.7% | -261.2% | -130.9% | -21.6% | 31.9% | -53.7% | 187.2% |
|
Shares outstanding (basic) [+] | 94.5 | 62.4 | 11.8 | 8.6 | 6.2 | 3.4 | 2.9 | 0.4 |
Growth | 51.5% | 430.0% | 36.4% | 38.8% | 80.5% | 18.2% | 609.3% | -97.1% |
Shares outstanding (diluted) [+] | 94.5 | 62.4 | 11.8 | 8.6 | 6.2 | 3.4 | 2.9 | 0.4 |
Growth | 51.5% | 430.0% | 36.4% | 38.8% | 80.5% | 18.2% | 609.3% | -97.1% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |